ERCP in Super-aged Patients Considering Difficult Cannulation: Challenges and Adverse Events
1 other identifier
observational
614
1 country
1
Brief Summary
Today 11 percent of China's population is over the age of 65, and according to United Nations, it will take China just 20 years for the proportion of the elderly population to double to 25%. As life expectancy has increased, application of Endoscopic Retrograde Cholangiopancreatography (ERCP) in super-aged (≥80 years of age) is no longer limited with increasing prevalence of choledocholithiasis, and malignancy in advancing age. This increasing may come with more difficulty in cannulation or more complications in senior patients. Regarding difficult cannulation, little is known about grading difficulty in the elderly and its relation with adverse events. Therefore, it is time to evaluate the risk factors of adverse events in super-aged patients with difficult bile duct cannulation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2018
CompletedFirst Submitted
Initial submission to the registry
October 7, 2018
CompletedFirst Posted
Study publicly available on registry
December 11, 2018
CompletedDecember 11, 2018
February 1, 2018
1.6 years
October 7, 2018
December 8, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Adverse events in difficult cannulation patients
Multi-variate regression will be used to check the risk factors of adverse events
30 days
Study Arms (2)
More 80
The first group included ERCP patients aged 80 and above.
Less 80
The second group included those ERCP patients younger than 80.
Interventions
Eligibility Criteria
No specific restrictions on selecting the patients.
You may qualify if:
- Patients who underwent ERCP between July 2016 and January 2018.
You may not qualify if:
- We excluded the patients who underwent ERCP for the objectives of follow up, stent removing or taking a biopsy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, 210011, China
Related Publications (1)
Tabak F, Ji GZ, Miao L. Impact of periampullary diverticulum on biliary cannulation and ERCP outcomes: a single-center experience. Surg Endosc. 2021 Nov;35(11):5953-5961. doi: 10.1007/s00464-020-08080-8. Epub 2020 Oct 7.
PMID: 33029732DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lin Miao, PhD
Nanjing Medical University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 30 Days
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 7, 2018
First Posted
December 11, 2018
Study Start
July 1, 2016
Primary Completion
January 30, 2018
Study Completion
March 1, 2018
Last Updated
December 11, 2018
Record last verified: 2018-02